Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, Cantor Fitzgerald Ink Stock Transaction Agreement

NEW YORK(GenomeWeb) – Affymetrix said on Tuesday that it has signed an agreement with Cantor Fitzgerald for the potential sale of Affymetrix's stock.

Under the terms of the deal, disclosed in a document filed with the US Securities and Exchange Commission, Affy may offer and sell its shares from time to time through the investment bank acting as Affy's agent. Any sale will be made under Affy's shelf registration filed in June 2012 to offer up to $50 million of its shares. 

The company's shares will be sold at market price or at a price agreed upon by Affy and Cantor Fitzgerald. Affy may also sell shares to Cantor Fitzgerald for its own account under terms agreed upon by the two companies. 

Affy recently noted in its third quarter report that it had $68.3 million in cash and cash equivalents as of Sept. 30.

In morning trading on Wednesday Affy's stock was down almost 4 percent on the Nasdaq at $9.22.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.